🇺🇸 FDA
Patent

US 7476721

Modified cytokines for use in cancer therapy

granted A61KA61K2039/505A61K2800/412

Quick answer

US patent 7476721 (Modified cytokines for use in cancer therapy) held by FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Grant date
Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K2800/412, A61K31/70, A61K38/191